APA

Li H., Tan J., Li J., Liu N., Chen J., Lv X., Zou L., Dong B., Peng Z. & Jiang J. (20200113). A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Chicago

Li Hu, Tan Jia-Li, Li Jian-Rui, Liu Nan-Nan, Chen Jin-Hua, Lv Xiao-Qin, Zou Li-Li, Dong Biao, Peng Zong-Gen and Jiang Jian-Dong. 20200113. A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Harvard

Li H., Tan J., Li J., Liu N., Chen J., Lv X., Zou L., Dong B., Peng Z. and Jiang J. (20200113). A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

MLA

Li Hu, Tan Jia-Li, Li Jian-Rui, Liu Nan-Nan, Chen Jin-Hua, Lv Xiao-Qin, Zou Li-Li, Dong Biao, Peng Zong-Gen and Jiang Jian-Dong. A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 20200113.